TransCelerate’s Clinical Quality Management System: From a Vision to a Conceptual Framework

The Quality Management System (QMS) initiative of TransCelerate BioPharma Inc has identified potential benefits that could be captured from the development of a flexible, proactive clinical QMS conceptual framework for clinical research. Such a framework would aid organizations in seamlessly managin...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic innovation & regulatory science 2016-07, Vol.50 (4), p.397-413
Main Authors: Meeker-O’Connell, Ann, Sam, Leslie M., Bergamo, Nanci, Little, Janis A.
Format: Article
Language:English
Subjects:
Authorship
Clinical trials
Collaboration
Compliance
Decision making
Design
Drug Safety and Pharmacovigilance
Feedback
Good Manufacturing Practice
Knowledge management
Patient safety
Patients
Pharmaceutical industry
Pharmacotherapy
Pharmacy
Quality management
R&D
Research & development
Risk assessment
Sponsored Special Section by TransCelerate BioPharma: Analytical Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Quality Management System (QMS) initiative of TransCelerate BioPharma Inc has identified potential benefits that could be captured from the development of a flexible, proactive clinical QMS conceptual framework for clinical research. Such a framework would aid organizations in seamlessly managing the complex clinical trial environment and, ultimately, in expediting delivery of needed treatments to patients. This article chronicles the evolution of a TransCelerate concept paper describing a proposed clinical QMS framework and reviews feedback from varied global clinical trial stakeholders during socialization of the concept paper. Many stakeholders recognized the potential for the concept paper to inform development of a harmonized International Council for Harmonisation (ICH) guideline, providing needed clarity from regulators on their expectations for QMS in the clinical realm. Accordingly, the article also describes TransCelerate’s efforts to work with regulators to facilitate harmonization on this important topic and reviews ongoing work to develop additional tools and resources that may support organizations in evaluating whether and how they might translate the conceptual framework principles into practice.
ISSN:2168-4790
2168-4804
DOI:10.1177/2168479016651300